ArticleMedicine2021

Erlotinib combined with bevacizumab and chemotherapy in first line osimertinib-resistant NSCLC patient with leptomeningeal metastasis: A case report.

Musen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.